Abstract
On average, adults who smoke cigarettes weigh less than nonsmokers. However, they have a greater tendency towards abdominal obesity, and, when they stop smoking, about 80% of them gain weight. Whereas original estimates of the amount of weight ex-smokers gain in one-years time was about five pounds, long-term follow-up of sustained quitters suggests that the weight gain may be considerably greater. While the health benefits of quitting smoking outweigh the adverse health consequences of post-cessation weight gain, studies on the effects of smoking cessation on lung function show that the weight gained by quitters may significantly reduce the beneficial effects of smoking cessation on lung function. Prevention of post-cessation weight gain has proved to be an elusive target. However, studies show that life style changes, diet, exercise, and pharamacotherapy, alone and in combination, may reduce post-cessation weight gain, at least for the period of time that the treatments are in effect. Nicotine replacement therapy, bupropion SR, and, to a lesser extent, varenicline, are the most effective pharmacological deterrents to post-cessation weight gain, although the latter medication may yield the best quit smoking results. Research on pharmacogenetics and other medications may increase physicians armamentarium in the future.
Current Respiratory Medicine Reviews
Title: Smoking and Weight
Volume: 4 Issue: 2
Author(s): Norman Hymowitz
Affiliation:
Abstract: On average, adults who smoke cigarettes weigh less than nonsmokers. However, they have a greater tendency towards abdominal obesity, and, when they stop smoking, about 80% of them gain weight. Whereas original estimates of the amount of weight ex-smokers gain in one-years time was about five pounds, long-term follow-up of sustained quitters suggests that the weight gain may be considerably greater. While the health benefits of quitting smoking outweigh the adverse health consequences of post-cessation weight gain, studies on the effects of smoking cessation on lung function show that the weight gained by quitters may significantly reduce the beneficial effects of smoking cessation on lung function. Prevention of post-cessation weight gain has proved to be an elusive target. However, studies show that life style changes, diet, exercise, and pharamacotherapy, alone and in combination, may reduce post-cessation weight gain, at least for the period of time that the treatments are in effect. Nicotine replacement therapy, bupropion SR, and, to a lesser extent, varenicline, are the most effective pharmacological deterrents to post-cessation weight gain, although the latter medication may yield the best quit smoking results. Research on pharmacogenetics and other medications may increase physicians armamentarium in the future.
Export Options
About this article
Cite this article as:
Hymowitz Norman, Smoking and Weight, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222830
DOI https://dx.doi.org/10.2174/157339808784222830 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A<sub>2</sub> (Lp-PLA<sub>2</sub>) Bound to LDL and HDL
Current Pharmaceutical Design Air Pollution, Platelet Activation and Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Cardiovascular Effects of Coumarins Besides their Antioxidant Activity
Current Topics in Medicinal Chemistry Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen
CNS & Neurological Disorders - Drug Targets One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design The Role of Hyphenated Chromatography-Mass Spectrometry Techniques in Exploratory Drug Metabolism and Pharmacokinetics
Current Pharmaceutical Design The Role of microRNA-126 in Vascular Homeostasis
Current Vascular Pharmacology Editorial [Hot topic:Vascular Protective Effects of Ezetimibe: Seeking New Therapeutic Possibilities of Ezetimibe in Vascular Disease (Guest Editor: Minako Yamaoka-Tojo)]
Current Vascular Pharmacology Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis
Current Pharmaceutical Design Endoplasmic Reticulum Stress-induced Transcriptional Factor CHOP and Cardiovascular Diseases
Current Hypertension Reviews Preface
Current Cardiology Reviews CCR2 Antagonists
Current Topics in Medicinal Chemistry Small Molecules as Anti-TNF Drugs
Current Medicinal Chemistry Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Telomere/Telomerase System: A New Target of Statins Pleiotropic Effect?
Current Vascular Pharmacology Cell Therapy for Myocardial Regeneration
Current Molecular Medicine Use of Diuretics in Women for Management of Hypertension
Current Hypertension Reviews